triiodothyronine has been researched along with esmolol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Christ, M; Feuring, M; Georgens, AC; Martin, N; Schmidt, BM; Tillmann, HC; Wehling, M | 1 |
Burman, KD; Carroll, NM; Devdhar, M; Popoveniuc, G; Sharma, M; Wartofsky, L; Wexler, JA | 1 |
1 review(s) available for triiodothyronine and esmolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for triiodothyronine and esmolol
Article | Year |
---|---|
Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiac Output; Cardiography, Impedance; Cardiovascular System; Cross-Over Studies; Diagnosis, Computer-Assisted; Dobutamine; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Male; Propanolamines; Reference Values; Triiodothyronine; Vascular Resistance | 2002 |
2 other study(ies) available for triiodothyronine and esmolol
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Calcium Channel Blockers; Diltiazem; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Organ Size; Prednisone; Propanolamines; Propranolol; Radiography; Thymus Gland; Thymus Hyperplasia; Thyroidectomy; Thyrotoxicosis; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine; Young Adult | 2010 |